New York State Teachers Retirement System Sells 4,000 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

New York State Teachers Retirement System lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,790 shares of the company’s stock after selling 4,000 shares during the period. New York State Teachers Retirement System owned 0.12% of Prestige Consumer Healthcare worth $4,513,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in PBH. Huntington National Bank grew its position in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after acquiring an additional 181 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Prestige Consumer Healthcare by 7,112.5% in the 3rd quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after purchasing an additional 1,138 shares during the period. Covestor Ltd grew its holdings in shares of Prestige Consumer Healthcare by 95.6% during the 3rd quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after acquiring an additional 654 shares during the period. GAMMA Investing LLC lifted its position in Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock valued at $108,000 after buying an additional 220 shares during the period. Finally, Blue Trust Inc. grew its holdings in Prestige Consumer Healthcare by 102.4% in the third quarter. Blue Trust Inc. now owns 1,755 shares of the company’s stock worth $121,000 after purchasing an additional 888 shares during the period. Institutional investors own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Canaccord Genuity Group upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a research note on Monday, December 9th. Finally, DA Davidson upped their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Trading Down 0.0 %

Shares of PBH stock opened at $84.85 on Friday. The company has a market cap of $4.20 billion, a PE ratio of 19.87, a price-to-earnings-growth ratio of 2.70 and a beta of 0.50. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The stock’s 50 day simple moving average is $79.42 and its two-hundred day simple moving average is $76.38. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.